Allergan, a global pharmaceutical company based in Dublin, has issued a voluntary recall for Biocell textured breast implants and tissue expanders after the action was requested by the FDA. The implants have been linked with several health problems and complications, including a rare form of cancer and death.

"It's important to quantify exposure to ionizing radiation because it can cause cancer and birth defects and should be kept to a minimum, especially during pregnancy," said co-lead author Marilyn L. Kwan, PhD.

Members of Congress have urged the Military Health System (MHS) to cover digital breast tomosynthesis (DBT) for all active and retired military personnel who take part in the TRICARE health insurance program.

Wendy J. Stirnkorb, CRA, RT (R) (MR), MRSO (MRSC), began her presentation July 22 at the AHRA 2019 Annual Meeting in Denver, Colorado, with a few basic questions for the audience.

CMS Administrator Seema Verma does not support expanding the government-sponsored healthcare programs she oversees to all Americans.

With Medicare for all on the lips of many Democratic presidential candidates and public support for universal healthcare coverage at its highest ever, concerns about healthcare usage under such a system have arisen. However, hospital use isn’t likely to rise under a Medicare-for-all plan, according to research published in the Annals of Internal Medicine.

U.S. Representative Chrissy Houlahan (D-PA), along with numerous other members of Congress, addressed a letter to the Military Health System (MHS) urging its leadership to provide DBT coverage to TRICARE health beneficiaries.

Nearly two-thirds of high-risk patients prescribed PCSK9 inhibitors to lower their risk of familial hypercholesterolemia and ASCVD are rejected coverage for the drugs by their health insurers, a new study alleges.